Agios COO Duncan Higgons To Step Down After New Year

In a regulatory filing late Friday, Agios Pharmaceuticals (NASDAQ: AGIO) of Cambridge, MA, reported that chief operating officer Duncan Higgons is leaving the company “to pursue other interests.” Previous to Agios, Higgons was COO of Archemix from 2006 to 2009 and chief commercial officer of Transform Pharmaceuticals from 2002 to 2005. His final day at Agios is Jan. 15.

Alex Lash is Xconomy's National Biotech Editor. He is based in San Francisco. Follow @alexlash

Trending on Xconomy